3.Liquidity

The Company has had no revenues from product sales and has incurred operating losses since inception. As of September 30, 2020, the Company had $32.0 million in cash and cash equivalents and during the year ended September 30, 2020 incurred a loss from operations of $17.1 million and used $10.7 million of cash in operating activities.

The Company has historically funded its operations through the sale of common stock and the issuance of convertible notes and warrants. The Company expects to continue to incur significant operating losses for the foreseeable future and may never become profitable. As a result, the Company will likely need to raise additional capital through one or more of the following: the issuance of additional debt or equity or the completion of a licensing transaction for one or more of the Company’s pipeline assets. Management believes that it has sufficient working capital on hand to fund operations through at least the next twelve months from the date these consolidated financial statements were issued. There can be no assurance that the Company will be successful in acquiring additional funding, that the Company’s projections of its future working capital needs will prove accurate, or that any additional funding would be sufficient to continue operations in future years.